<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The pattern of immune system gene rearrangements in <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_336'>leukaemias</z:mpath> of childhood is <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The biological significance of this <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> in childhood <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_336'>leukaemia</z:mpath> is still poorly understood </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, we analysed 49 children with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_336'>leukaemia</z:mpath> (29 B-precursor <z:hpo ids='HP_0011009'>acute</z:hpo> lymphoblastic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> (ALL), 5 relapsed <z:e sem="disease" ids="C1292769" disease_type="Neoplastic Process" abbrv="">cALL</z:e>, 6 T-ALL, 7 <z:hpo ids='HP_0011009'>acute</z:hpo> non-lymphocytic (ANLL) and 2 mixed lineage <z:mpath ids='MPATH_336'>leukaemias</z:mpath>), for the presence of different immune system gene rearrangements (Ig JH, C kappa, C lambda, TCR J gamma, C beta, J delta and J alpha) by Southern blot hybridisation </plain></SENT>
<SENT sid="3" pm="."><plain>The most prominent <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> of immune system gene rearrangements was observed in the group of B-precursor ALL </plain></SENT>
<SENT sid="4" pm="."><plain>The results from our study suggest that the <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> of immune system gene rearrangement reflects clonal diversity in approximately one-third of patients with B-precursor ALL at presentation and in most patients in relapse </plain></SENT>
<SENT sid="5" pm="."><plain>The observed association of clonal diversity with high white blood cell count, pre-B immunophenotype and age under 1 year in B-precursor ALL may have clinical significance </plain></SENT>
<SENT sid="6" pm="."><plain>There was a significantly shorter disease-free survival in the group of B-precursor ALL patients with clonal diversity compared with those without clonal diversity </plain></SENT>
<SENT sid="7" pm="."><plain>Clonal diversity may, therefore, be a mechanism of disease progression common to different types of aggressive B-precursor ALL </plain></SENT>
</text></document>